Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
05 09 2023
05 09 2023
Historique:
medline:
7
9
2023
pubmed:
6
9
2023
entrez:
6
9
2023
Statut:
epublish
Résumé
The Apgar score is used worldwide as an assessment tool to estimate the vitality of newborns in their first minutes of life. Its applicability to estimate neurodevelopmental outcomes in infants born extremely preterm (EPT; <28 weeks' gestation) is not well established. To investigate the association between the Apgar score and neurodevelopmental outcomes in infants born EPT. This cohort study was conducted using data from the Effective Perinatal Intensive Care in Europe-Screening to Improve Health in Very Preterm Infants in Europe (EPICE-SHIPS) study, a population-based cohort in 19 regions of 11 European countries in 2011 to 2012. Clinical assessments of cognition and motor function at age 5 years were performed in infants born EPT and analyzed in January to July 2023. Apgar score at 5 minutes of life categorized into 4 groups (0-3, 4-6, 7-8, and 9-10 points). Cognitive and motor outcomes were assessed using the Wechsler Preschool and Primary Scale of Intelligence test of IQ derived from locally normed versions by country and the Movement Assessment Battery for Children-Second Edition. Parents additionally provided information on communication and problem-solving skills using the Ages and Stages Questionnaire, third edition (ASQ-3). All outcomes were measured as continuous variables. From the total cohort of 4395 infants born EPT, 2522 infants were live born, 1654 infants survived to age 5 years, and 996 infants (478 females [48.0%]) followed up had at least 1 of 3 outcome measures. After adjusting for sociodemographic variables, perinatal factors, and severe neonatal morbidities, there was no association of Apgar score with IQ, even for scores of 3 or less (β = -3.3; 95% CI, -10.5 to 3.8) compared with the score 9 to 10 category. Similarly, no association was found for ASQ-3 (β = -2.1; 95% CI, -24.6 to 20.4). Congruent results for Apgar scores of 3 or less were obtained for motor function scores for all children (β = -4.0; 95% CI, -20.1 to 12.1) and excluding children with a diagnosis of cerebral palsy (β = 0.8, 95% CI -11.7 to 13.3). This study found that low Apgar scores were not associated with longer-term outcomes in infants born EPT. This finding may be associated with high interobserver variability in Apgar scoring, reduced vitality signs and poorer responses to resuscitation after birth among infants born EPT, and the association of more deleterious exposures in the neonatal intensive care unit or of socioeconomic factors with greater changes in outcomes during the first 5 years of life.
Identifiants
pubmed: 37672271
pii: 2808959
doi: 10.1001/jamanetworkopen.2023.32413
pmc: PMC10483322
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2332413Investigateurs
Jo Lebeer
(J)
Patrick van Reempts
(P)
Els Bruneel
(E)
Eva Cloet
(E)
Ann Oostra
(A)
Els Ortibus
(E)
Iemke Sarrechia
(I)
Klaus Boerch
(K)
Lene Huusom
(L)
Pernille Pedersen
(P)
Asbjørn Hasselager
(A)
Liis Toome
(L)
Mairi Männamaa
(M)
Pierre-Yves Ancel
(PY)
Antoine Burguet
(A)
Pierre Jarreau
(P)
Véronique Pierrat
(V)
Patrick Truffert
(P)
Björn Misselwitz
(B)
Stephan Schmidt
(S)
Lena Wohlers
(L)
Maria Cuttini
(M)
Domenico Di Lallo
(D)
Gina Ancora
(G)
Dante Baronciani
(D)
Virgilio Carnielli
(V)
Ileana Croci
(I)
Giacomo Faldella
(G)
Frederica Ferrari
(F)
Francesco Franco
(F)
Giancarlo Gargano
(G)
Arno van Heijst
(A)
Corine Koopman-Esseboom
(C)
Janusz Gadzinowski
(J)
Jan Mazela
(J)
Alan Montgomery
(A)
Tomasz Pikuła
(T)
Henrique Barros
(H)
Raquel Costa
(R)
Luís Graça
(L)
Maria do Céu Machado
(M)
Carina Rodrigues
(C)
Teresa Rodrigues
(T)
Anna-Karin Edstedt Bonamy
(AK)
Mikael Norman
(M)
Elaine Boyle
(E)
Alan Fenton
(A)
Samantha Johnson
(S)
Bradley Manktelow
(B)
David Milligan
(D)
Silke Mader
(S)
Nicole Thiele
(N)
Johanna Walz
(J)
Stavros Petrou
(S)
Mercedes Bonet
(M)
Camille Bonnet
(C)
Rym El Raffei
(R)
Aurélie Piedvache
(A)
Anna-Veera Seppänen
(AV)
Références
Circulation. 2020 Oct 20;142(16_suppl_1):S185-S221
pubmed: 33084392
Arch Dis Child Fetal Neonatal Ed. 2021 Jul;106(4):413-417
pubmed: 33452221
BMC Pregnancy Childbirth. 2013 Oct 03;13:182
pubmed: 24090495
J Pediatr. 2000 Nov;137(5):608-16
pubmed: 11060524
JAMA Pediatr. 2023 Feb 1;177(2):177-186
pubmed: 36648921
Semin Fetal Neonatal Med. 2022 Jun;27(3):101345
pubmed: 35550785
BMJ. 2010 Oct 06;341:c4990
pubmed: 20929920
Biometrics. 2012 Mar;68(1):129-37
pubmed: 22050039
Arch Dis Child Fetal Neonatal Ed. 2022 Jan;107(1):113-114
pubmed: 33568495
Paediatr Perinat Epidemiol. 2017 Jul;31(4):338-345
pubmed: 28621463
Arch Dis Child Fetal Neonatal Ed. 2023 Jan;108(1):2-9
pubmed: 35228320
Pediatrics. 2022 Jun 1;149(6):
pubmed: 35615946
N Engl J Med. 2020 Jul 2;383(1):49-57
pubmed: 32609981
Neurotoxicology. 2017 Jul;61:47-53
pubmed: 27045882
Acta Paediatr. 2005 Jul;94(7):890-5
pubmed: 16188811
Curr Res Anesth Analg. 1953 Jul-Aug;32(4):260-7
pubmed: 13083014
Neonatology. 2022;119(4):464-473
pubmed: 35526524
J Pediatr. 2006 Oct;149(4):486-9
pubmed: 17011319
JAMA. 2009 Nov 25;302(20):2235-42
pubmed: 19934425
Pediatrics. 2015 Oct;136(4):819-22
pubmed: 26416932
Arch Dis Child Fetal Neonatal Ed. 2016 Mar;101(2):F121-6
pubmed: 26297221
Obstet Gynecol. 2001 Jul;98(1):65-70
pubmed: 11430958
PLoS Med. 2022 Jul 12;19(7):e1004040
pubmed: 35819949
Int J Epidemiol. 2020 Apr 1;49(2):372-386
pubmed: 32031620
JAMA Pediatr. 2021 Oct 1;175(10):1035-1042
pubmed: 34279561
Dev Med Child Neurol. 2010 Jun;52(6):e119-25
pubmed: 20163431
Pediatrics. 2012 Oct;130(4):e982-7
pubmed: 23008464
BMJ. 2021 Apr 28;373:n741
pubmed: 33910920
Pediatrics. 2022 Apr 1;149(4):
pubmed: 35296895
BJOG. 2016 Mar;123(4):559-68
pubmed: 25753683
BMJ. 2019 May 7;365:l1656
pubmed: 31064770
Semin Fetal Neonatal Med. 2020 Jun;25(3):101116
pubmed: 32461044
N Engl J Med. 2015 Jan 22;372(4):331-40
pubmed: 25607427
Pediatrics. 2013 Aug;132(2):e372-80
pubmed: 23878051
Pediatrics. 1999 Apr;103(4):e56
pubmed: 10103348
JAMA Netw Open. 2022 Feb 1;5(2):e2146404
pubmed: 35129596
Pediatr Res. 2023 Aug;94(2):771-780
pubmed: 36694025
BMJ Open. 2019 May 9;9(5):e027655
pubmed: 31072859
Acta Obstet Gynecol Scand. 2011 Oct;90(10):1070-81
pubmed: 21682697
Pediatrics. 2018 Apr;141(4):
pubmed: 29567814
Int J Epidemiol. 2022 Jan 6;50(6):1824-1839
pubmed: 34999864
Arch Dis Child Fetal Neonatal Ed. 2022 May;107(3):317-323
pubmed: 34509987
BMJ. 2010 May 13;340:c1471
pubmed: 20466789
BMC Pediatr. 2015 Mar 08;15:18
pubmed: 25884954
J Pediatr. 2001 Jun;138(6):798-803
pubmed: 11391319
Semin Perinatol. 2016 Dec;40(8):497-509
pubmed: 27865437
Dev Med Child Neurol. 2022 Sep;64(9):1131-1144
pubmed: 35298035
Arch Dis Child Fetal Neonatal Ed. 2013 Nov;98(6):F473-9
pubmed: 23896791
BMC Med Res Methodol. 2021 Jun 6;21(1):118
pubmed: 34092226
Dev Med Child Neurol. 2016 Mar;58 Suppl 4:46-52
pubmed: 27027607
Lancet. 2014 Nov 15;384(9956):1749-55
pubmed: 25236409
Arch Dis Child Fetal Neonatal Ed. 2017 Sep;102(5):F400-F408
pubmed: 28232518
Pediatrics. 2014 Jan;133(1):55-62
pubmed: 24379238
BJOG. 2018 Jan;125(1):16-25
pubmed: 29024294
Arch Dis Child Fetal Neonatal Ed. 2022 Jul;107(4):437-446
pubmed: 34782368
JAMA. 2015 Sep 8;314(10):1039-51
pubmed: 26348753
JAMA Pediatr. 2021 Aug 1;175(8):e211058
pubmed: 34047752
Int J Mol Sci. 2021 Oct 02;22(19):
pubmed: 34639034
Semin Fetal Neonatal Med. 2014 Apr;19(2):84-9
pubmed: 24290908
Arch Dis Child Fetal Neonatal Ed. 2016 Mar;101(2):F114-20
pubmed: 26187935
Early Hum Dev. 2020 Jul;146:105056
pubmed: 32470764
Neonatology. 2022;119(6):669-685
pubmed: 36044835
Arch Dis Child Fetal Neonatal Ed. 2019 Jan;104(1):F36-F45
pubmed: 29353260
N Engl J Med. 2008 Apr 17;358(16):1672-81
pubmed: 18420500